Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Oncology | Neurology
Disease Category: Brain Cancer
Trial Information
Primary Brain Cancer - Adults
People with primary brain cancer (tumors in the brain) are asked
to participate in a research study being conducted by Mount Sinai
School of Medicine.
You may be eligible to participate in this study if
you:
- Are at least 18 years of age
- Have been diagnosed or relapsed with primary brain
cancer
You may not participate in this study if
you:
- Have had serious hypersensitivity reactions to Cremophor®
EL
- Have greater than second relapse. Relapse is defined as
progression following attempted curative therapy (with or without
chemotherapy).
- Have had treatment with platinum-based chemotherapy
- Have a history of cardiovascular disease or stroke
- Have history of high blood pressure
- Are pregnant, breastfeeding, or intend to become pregnant
during the study
- Have participated in another research study within the last 30
days
Mirela E. Toma, Study Coordinator
Biomedical Research Alliance of New York
Mount Sinai School of Medicine
One Gustave L. Levy Place, Box 1052
New York, NY 10029
Phone: 212-241-0762
Fax: 212-987-3301
EMail: mirela.toma@mssm.edu
View Google Map
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
